Mold Medics vs 76 Fence

Brand A is the stronger opportunity right now for one reason that overrides every other metric on the table: a single franchised unit generating $1.54M AUV on a controlled procurement model. That means the franchisor dictates what technology the franchisee buys. You don’t need to sell 100 owners; you need to sell one decision-maker who already controls the stack, and that one franchisee is contractually bound to follow. The $315K high-end investment bracket signals budget headroom, and an 8% royalty on $1.54M tells you the franchisor has serious cash flow incentive to standardize operations and protect margins—exactly the pain point your POS, scheduling, and back-office tools solve.

Brand B is a ghost in this comparison. Having a 2026 FDD filed on time is a compliance victory, not a sales signal. Without unit counts, AUV, procurement structure, or investment range, Mold Medics is an unknown quantity dressed in administrative punctuality. You’d be selling blind into a black box with no evidence of spend capacity, no levers on centralized purchasing, and no way to size the deal. The terrain dimension is completely absent, and timing alone doesn’t open a checkbook.

The tradeoff is scale versus certainty. Brand A is microscopically small—two total units—so your TAM is a rounding error. But a tightly controlled, high-revenue franchise system with a single buyer is a high-probability, short-cycle deal that pays off now. Mold Medics might have a bigger total market someday, but today you have zero data to prove it.

Verdict: 76 Fence’s franchisor-controlled procurement on a $1.54M AUV unit is a target you can close; Mold Medics is a filing date waiting for a business case.